Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1943 1
1951 1
1955 1
1956 2
1957 3
1958 3
1960 4
1961 1
1963 3
1966 2
1967 1
1968 1
1970 1
1971 2
1972 4
1973 6
1974 8
1975 10
1977 4
1978 11
1979 2
1980 10
1981 7
1982 11
1983 6
1984 7
1985 11
1986 8
1987 15
1988 14
1989 8
1990 16
1991 5
1992 19
1993 21
1994 14
1995 12
1996 13
1997 15
1998 23
1999 13
2000 15
2001 18
2002 19
2003 24
2004 22
2005 40
2006 30
2007 31
2008 29
2009 30
2010 31
2011 45
2012 36
2013 49
2014 37
2015 34
2016 38
2017 39
2018 62
2019 54
2020 39
2021 59
2022 45
2023 50
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,102 results

Results by year

Filters applied: . Clear all
Page 1
MYC as a target for cancer treatment.
Duffy MJ, O'Grady S, Tang M, Crown J. Duffy MJ, et al. Cancer Treat Rev. 2021 Mar;94:102154. doi: 10.1016/j.ctrv.2021.102154. Epub 2021 Jan 19. Cancer Treat Rev. 2021. PMID: 33524794 Free article. Review.
Targeting p53 for the treatment of cancer.
Duffy MJ, Synnott NC, O'Grady S, Crown J. Duffy MJ, et al. Semin Cancer Biol. 2022 Feb;79:58-67. doi: 10.1016/j.semcancer.2020.07.005. Epub 2020 Jul 31. Semin Cancer Biol. 2022. PMID: 32741700 Free article. Review.
Functional Gastrointestinal Disorders.
Duffy M, Boggiano VL, Ganesh R, Mueller M. Duffy M, et al. Prim Care. 2023 Sep;50(3):429-446. doi: 10.1016/j.pop.2023.03.006. Epub 2023 Apr 29. Prim Care. 2023. PMID: 37516512 Review.
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma.
Rialdi A, Duffy M, Scopton AP, Fonseca F, Zhao JN, Schwarz M, Molina-Sanchez P, Mzoughi S, Arceci E, Abril-Fornaguera J, Meadows A, Ruiz de Galarreta M, Torre D, Reyes K, Lim YT, Rosemann F, Khan ZM, Mohammed K, Wang X, Yu X, Lakshmanan M, Rajarethinam R, Tan SY, Jin J, Villanueva A, Michailidis E, De Jong YP, Rice CM, Marazzi I, Hasson D, Llovet JM, Sobota RM, Lujambio A, Guccione E, Dar AC. Rialdi A, et al. Among authors: duffy m. Nat Cancer. 2023 Aug;4(8):1157-1175. doi: 10.1038/s43018-023-00609-9. Epub 2023 Aug 3. Nat Cancer. 2023. PMID: 37537299 Free PMC article.
Structural basis for the action of the drug trametinib at KSR-bound MEK.
Khan ZM, Real AM, Marsiglia WM, Chow A, Duffy ME, Yerabolu JR, Scopton AP, Dar AC. Khan ZM, et al. Among authors: duffy me. Nature. 2020 Dec;588(7838):509-514. doi: 10.1038/s41586-020-2760-4. Epub 2020 Sep 14. Nature. 2020. PMID: 32927473 Free PMC article.
1,102 results